ANGPTL4 and cardiovascular disorder: Large-scale human genetic studies demonstrate that individuals bearing loss-of-function ANGPTL4 variants have significant lower level of TGs and reduced risk of cardiovascular diseases (Gusarova et al., 2018, Myocardial Infarction et al., 2016; Dewey et al., 2016).